GSK 10Pn-PD-DiT 4-dose Presentation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 10Pn-PD-DiT 4-dose Presentation, covering 2017-03-16 to 2017-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants [Phase 3]